Varian Medical Systems (VAR) is expected to report its earnings for the fourth quarter of fiscal 2018 on October 23.
In this series, we’ll take a look at Varian’s expected top line, operational, and bottom line performances in the quarter. We’ll also consider analysts’ recommendations for the stock and its performance so far this year.
Varian Medical Systems is focused on the design, manufacture, and commercialization of hardware and software products targeted at treating cancer with radiotherapy, stereotactic radiosurgery, brachytherapy, and stereotactic body radiotherapy. Varian’s software services include informatics software, clinical knowledge exchange, patient care management, and practice management.
Top line forecast
Analysts expect Varian Medical Systems’ revenue to rise 3.69% from $739.0 million in the fourth quarter of fiscal 2017 to $766.26 million in the fourth quarter of fiscal 2018. In the fourth quarter of fiscal 2017, its revenue fell 19.01%. The upcoming quarter could mark the third consecutive quarter of revenue uptick for Varian after four consecutive quarters of revenue falls.
For fiscals 2018 and 2019, Varian Medical Systems is expected to generate revenues of $2.88 billion and $2.99 billion, respectively. In fiscal 2017, Varian generated revenue of $2.67 billion.
We’ll take a look at Varian Medical Systems’ expected operational performance for the fourth quarter of fiscal 2018 in the next article.